BioEclosion — Grant · approximately €450K

BioEclosion coordinates the AmpliSens project (rapid molecular test for Group B streptococcus in newborns and pregnant women), with UAB, ISGlobal and Eurecat as partners. It is funded by the Ministry of Science and Innovation and NextGenerationEU/PRTR under the 'Proyectos de colaboración público-privada 2021' call (ref. CPP2021-008459). Total funding is €450,164.50 for Sept 2022 to Aug 2025. BioEclosion's own share is not disclosed. The date given is the project start.